Q/C Technologies, Inc. (QCLS) — 8-K/A Filings

All 8-K/A filings from Q/C Technologies, Inc.. Browse 4 Amended Current Event Report reports with AI-powered summaries and risk analysis.

8-K/A Filings (4)

  • Q/C Technologies Files 8-K/A Amendment — Oct 6, 2025 Risk: low
    Q/C Technologies, Inc. filed an amendment (8-K/A) on October 6, 2025, reporting events as of September 30, 2025. The filing pertains to the departure of directo
  • TNF Pharmaceuticals Files 8-K/A Amendment — Sep 5, 2025 Risk: low
    TNF Pharmaceuticals, Inc. filed an 8-K/A on September 5, 2025, to amend a previous filing related to financial statements and exhibits as of September 2, 2025.
  • MyMD Pharmaceuticals Files 8-K Amendment — Jun 20, 2024 Risk: medium
    MyMD Pharmaceuticals, Inc. filed an amendment (8-K/A) on June 20, 2024, to a previous filing concerning a material definitive agreement entered into on May 20,
  • MyMD Pharmaceuticals Files 8-K Amendment — Mar 26, 2024 Risk: low
    MyMD Pharmaceuticals, Inc. filed an amendment (Amendment No. 1) to its Form 8-K on March 26, 2024, regarding events that occurred on March 4, 2024. This amendme

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.